Oppenheimer: Time To Buy Leucadia Nat’l (NYSE:LUK)? Has $27 Valuation Target


Why Has Oppenheimer Given Leucadia Nat’l (NYSE:LUK) a $27 Price Target

Analysts at Oppenheimer have initiated coverage on shares of Leucadia Nat’l (NYSE:LUK) in an interesting research report revealed to clients and investors on Tuesday morning. The investment house set “Outperform” rating on the $6.60 billion market cap company.

Approximately 62,775 shares of stock traded hands. Leucadia National Corp. (NYSE:LUK) has declined 25.08% since April 28, 2015 and is downtrending. It has underperformed by 23.46% the S&P500.

Leucadia National Corporation is a diversified holding firm engaged through its subsidiaries in a variety of businesses. The company has a market cap of $6.60 billion. The Company’s business include capital markets and asset management. It has 32.43 P/E ratio.

According to Zacks Investment Research, “LEUCADIA NATL is a diversified financial services holding company principally engaged in personal and commercial lines of property and casualty insurance, life insurance, banking and lending and manufacturing. The Company concentrates on return on investment and cash flow to build long-term shareholder value, rather than emphasizing volume or market share. Additionally, the Company continuously evaluates the retention and disposition of its existing operations and investigates possible acquisitions of new businesses in order to maximize shareholder value.” Get a free copy of the Zacks research report on Leucadia National Corp. (LUK)